Navigation Links
Ginseng Associated with Pregnancy Risks

Ginseng is a popular herbal supplement thought to have anti-cancer properties and to boost stamina, improve physical and mental abilities, and help people cope with stress. Previous studies suggest it is regularly used by pregnant women, particularly in Asian countries. //

Studies done, found up to 10 percent of women had taken the supplement while pregnant. Another recent survey found about 9 percent of pregnant women were taking herbal supplements, including ginseng.

The current study out of Hong Kong measured fetal growth in rats that were and were not given an active ingredient in ginseng called ginsenoside. Results showed those who received more than 30 micrograms scored significantly lower on a standard test to assess organ development. The scores went down as the dose of the ginsenoside increased.

Researchers say, their study has demonstrated that ginsenoside exerts a direct teratogenic effect on rat embryos: that is to say it is capable of causing malformations in rat embryos .

However more research is called for to assess the possible effects of ginseng on human pregnancies, but according to their findings they suggest, “Use of ginseng during first trimester of pregnancy should be with caution.”


'"/>




Page: 1

Related medicine news :

1. Ginsengs efficacy debatable
2. Ginseng aids Diabetes
3. Mixing Ginseng and Blood Thinners Might Be Dangerous
4. Ginseng Improves The Survival Rates Of Breast Cancer
5. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
6. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
7. Associated therapy for multiple myeloma
8. Associated scan for detecting ovarian cancer spread
9. Enzyme Associated with Memory
10. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
11. Enzyme Associated With Memory
Post Your Comments:
(Date:7/3/2009)..., DEBRECEN, Hungary, July 3 Berta...nt, published a free e-guide for medical profe... used in medicine. Medical conferences are expensi...s for interaction. This eGuide helps doctors enter...s and meetings for free as Second Life provides op...
(Date:7/3/2009)...esearchers express hope that finding will lead to ...ay News) -- U.S. researchers say they,ve found a ...d of relapsed lung cancer. , When caught early,...are not detected until the disease is well advance...o remission, the disease often springs back more v...
(Date:7/3/2009)..., SHANGHAI, July 3 /PRNewswire-Asia/ -- Sundi...nd biotech R&D outsourcing company in Shanghai...en appointed Senior Vice,President of Chemistry S...n worked at Neurocrine Biosciences, a drug,discov...15 years, from a staff,scientist to Senior Direct...
(Date:7/3/2009)... Two companies and three i... excellence at an annual international competition...ampions. The 15,000-member SafetyXChange.org comm...ds on June 30, 2009 at http://www.safetyxchange.o...ple and organizations who dedicate their lives to ...
Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4
...and Testing (VCT) program in South Africa, has bee...een April 2005 and March 2006, the Department Of//...lmost doubled as compared to last year. Around 1,...efore testing. 80 percent went ahead and got teste...
...on people, is the fourth most populous nation in t...f a HIV explosion. At present Indonesia has// abou...ficial reports. But it is likely that there are mo...It is estimated that by the end of this decade Ind...
...ries, Japan is keen to have more Indian students f...h are currently restricted only to those// who kno...dergraduate courses like biotechnology and neurosc...hi Kurokawa, science adviser to Japan's prime mini...
...the Doha Asian Games suffered a major blow as Olym...ering from viral flu.// Maxwell de Silva, the dep...-year-old Sri Lankan sprint queen failed to come w...em but De Silva was hopeful that Jayasinghe will m...
Other Medicine News:
(Date:7/2/2009)...EUVEN, Belgium and LUND, Sweden, July 3 /PRNewswir...ls: THR) and co-development partner,BioInvent Int...arted,recruitment of a second cohort of patients ...completion of recruitment of the first cohort of 1... long acting anticoagulant that,is being develope...
(Date:7/2/2009)... and WOODCLIFF LAKE, N.J., July 2 ...mp; CEO: Haruo Naito, "Eisai") and Eisai Corporati... NJ, Chairman and CEO Hajime Shimizu) are currentl...for the company,s major product Aricept(R) (donepe...o patients with Alzheimer,s disease. As progress i...
(Date:7/1/2009)...VISTGAARD, Denmark, July 1 /PRNewswire-FirstCall/ ...pert Opinion on Investigational Drugs", Volume,18...formation on,PROSTVAC(TM). This is the most compr...r. , Quote from the article: "Preliminary c..., and Phase II trials have suggested a survival be...
(Date:6/30/2009)...THIAN, Va., June 30 In two recent ...ebulizer and PRONEB compressors (Ultra and Ultra I...arate (Perforomist, DEY LP, Mylan Inc.) improves p...searchers chose PARI products as the exclusive neb...nance treatments for COPD. Sutherland et al. used...
Breaking Medicine Technology:ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 5Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 3New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2LCA Vision Adopts Stockholder Rights Plan 30423 1LCA Vision Adopts Stockholder Rights Plan 30423 2LCA Vision Adopts Stockholder Rights Plan 30423 3Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 1Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 2Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 3Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 4Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea 30419 1Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea 30419 2Accordia Global Health Foundation Receives 2412 5 Million Grant From Bill 26 Melinda Gates Foundation 30417 1Accordia Global Health Foundation Receives 2412 5 Million Grant From Bill 26 Melinda Gates Foundation 30417 2
...007 - Affymax, Inc.,(Nasdaq:AFFY) today announced ... trials of Hematide(TM) in dialysis and,non-dialys... showed,that in treatment naive, non-dialysis pati...ed monthly at an appropriate dose.,Similarly, the ...three-times weekly Epoetin Alfa demonstrated that ...
...CytRx Corporation,(NASDAQ:CYTR) today announced th... exclusively licensed to its majority-owned,subsid...een,published in the April 2007 issue of peer-revi...technology was developed by RXi,Co-founder, Scient...chusetts Medical School (UMMS) Professor of Bioche...
Other Medicine Technology:Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 2Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4
...anal flare index. A/P and lateral fins with holes ...oximal medial hole, humeral / glenoid diametral cu...slation. Rough textured proximal surface to provid...otational resistance in cement, six stem sizes, fi...
BioPro Uni-compartmental Knee System - Uni-compartmental Tibial Tray
The Advance Unicompartmental Knee System is designed with bone conserving femoral and tibial components that provide reproducible results within a minimal incision. Uni metal backed tibial component.
Advance Uni-Comparental Knee Components - Uni All-poly Tibial Component
Medicine Products: